Interventional pulmonology [0.03%]
介入性肺病学
Imran Sulaiman
Imran Sulaiman
This issue of Breathe focuses on interventional pulmonology https://bit.ly/4ef45Lm. Copyright ©ERS 2025.
Pulmonary function prediction in lung cancer resection candidates: the latest insights [0.03%]
肺癌手术患者的肺功能预测：最新见解
Riccardo Orlandi,Sara Degiovanni,Clarissa Uslenghi et al.
Riccardo Orlandi et al.
Surgical resection remains the most effective curative option for early-stage nonsmall cell lung cancer (NSCLC) in fit patients. However, many individuals with NSCLC have comorbidities that elevate surgical risks and complicate postoperativ...
Henny Azmanov,Fares Darawshy
Henny Azmanov
Interventional pulmonology offers a range of minimally invasive techniques to manage airway pathologies, including central airway obstruction. This review examines three commonly used hot ablation therapies: argon plasma coagulation (APC), ...
The pathogenesis of bronchopulmonary dysplasia: "It is never the heart, it is always the lung" - myth or maxim? [0.03%]
支气管肺发育不良的发病机制：“不是心脏，始终是肺”- 是神话还是真理？
Alice Hadchouel,Christophe Delacourt
Alice Hadchouel
"This is not the heart; this is the lung." Who among paediatric pulmonologists has never faced this situation with a cardiologist? Joking aside, discussions for some cases may be tricky and our common ultimate goal is always to provide the ...
Present and future of paediatric interventional pulmonology: addressing global healthcare disparities [0.03%]
儿科介入性肺病学的现状与未来：应对全球医疗不平等问题
Dirk Schramm,Nor Diyana Ismail
Dirk Schramm
Paediatric interventional pulmonology has evolved significantly since the introduction of flexible bronchoscopy in the 1970s, transforming the diagnosis and treatment of paediatric respiratory conditions. This review examines the current st...
Claire Bradley,Nuria Novoa,Laura Riva et al.
Claire Bradley et al.
In this review, we explore the importance of accurate mediastinal staging in nonsmall cell lung cancer, which directly impacts management options and prognosis. We outline the various means of staging, including radiological and interventio...
Akash Gupta,Dirk-Jan Slebos,Simon D Pouwels
Akash Gupta
After decades of development and experience, lung implantable devices have proven to be invaluable in the management of respiratory diseases and complications. Unfortunately, granulation tissue hyperplasia remains a common and challenging c...
A new era in the treatment of progressive fibrosing interstitial lung diseases [0.03%]
进展性肺纤维化疾病的治疗新纪元
Anna Denis,Panagiota Tsiri,Julien Guiot et al.
Anna Denis et al.
Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are characterised by an irreversible progression of pulmonary fibrosis and functional lung decline. Current antifibrotic therapies (nintedanib and pirfenidone for ...
Accelerate your career: the power of the ERS interstitial lung disease mentorship programme [0.03%]
ERS间质性肺病导师项目的强大力量——加速您的职业生涯
Catharina C Moor,Laura Fabbri,Namrata Kewalramani et al.
Catharina C Moor et al.
Assembly 12 has developed an online and onsite mentoring programme for early career members. This article discusses the content of the programme, experiences from mentees and mentors and future plans. https://bit.ly/4iGBr6G. ...
Connective tissue disease-associated interstitial lung disease: a rheumatologist's perspective [0.03%]
结缔组织病相关间质性肺疾病：风湿科医师的视角
Áine Connerton,Eoghan McCarthy,Laura Durcan
Áine Connerton
Pulmonary involvement is common in patients with underlying autoimmune and connective tissue diseases (CTDs) and can encompass a broad spectrum of disorders involving the airways, pleura, parenchyma, vascular system, bronchiectasis and nodu...